|
| Exchange Disseminated Time | Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors at their Meeting held on August 06, 2015, at a Shorter Notice, interalia transacted the following business:
1. Approved the Shorter Notice of Board Meeting.
2. Approved the proposal for fresh issue of upto 26,50,000 Warrants at Rs.65/- each, on preferential basis to Shri. J B Pharma LLP, an entity forming part of the promoter group, subject to the approval of the Members, in the upcoming Annual General Meeting to be held on September 03, 2015, and in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations. Each warrant shall be convertible into 1 equity share of Rs.10/- each at a premium of Rs.55/- per equity share within a period of 18 months in one or more tranches from the date of allotment of warrants. |
|
|